The FDA is reviewing the first mRNA flu vaccine for adults 50 and older. Learn how this technology could lead to faster and more effective shots.
Hosted on MSN
How the mRNA technology behind COVID-19 vaccines could ‘turbo-charge’ cancer treatments
The mRNA technology from COVID-19 vaccines may help amplify cancer treatments that use the body’s own immune system to fight cancer, a new study has found. Cancer patients who received an mRNA-based ...
The Food and Drug Administration is refusing to consider Moderna's application for a new flu vaccine made with Nobel Prize-winning mRNA technology, the company announced Tuesday. The news is the ...
WASHINGTON — The U.S. Food and Drug Administration is refusing to consider Moderna’s application for a new flu vaccine made with Nobel Prize-winning mRNA technology, the company announced Tuesday. The ...
ALBANY, NY (NEWS10) — Six years ago this month, New York declared a state of emergency due to COVID-19. With the pandemic, the use of mRNA technology for vaccines became more mainstream. At UAlbany, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results